Gilead Sciences (GILD) PT Raised to $165 at Wells Fargo
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $125.59 -0.22%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Gilead Sciences (NASDAQ: GILD) to $165.00 (from $150.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Gilead donates remdesivir to Uganda for Ebola outbreak response
- Uber Inc. (UBER) PT Raised to $115 at Tigress Financial Partners
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$231 at Bernstein SocGen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
